Shortage reports
Actual shortage:
58 (4%)
Anticipated shortage:
2 (0%)
Avoided shortage:
37 (3%)
Resolved:
1273 (93%)
1370
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (16%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2023-04-14 | 2023-06-21 | 189587 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2023-04-14 | 2023-06-07 | 189584 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-07 | 2018-06-07 | 6105 |
| PMS-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-04-20 | 2018-06-29 | 7338 |
| PMS-BISACODYL | 10MG | SUPPOSITORY | Resolved | 2017-05-04 | 2020-06-10 | 8919 |
| PMS-BOSENTAN | 125MG | TABLET | Resolved | 2017-12-07 | 2018-02-17 | 32035 |
| PMS-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2017-03-13 | 2020-04-02 | 1774 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
| PMS-BUPRENORPHINE-NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2024-07-24 | 2024-10-09 | 233605 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-19 | 8925 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-08-11 | 2018-05-05 | 18860 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117873 |
| PMS-PRAMIPEXOLE | 0.50MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118132 |
| PMS-PRAMIPEXOLE | 1.0MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118129 |
| PMS-PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118126 |
| PMS-PRAVASTATIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117775 |
| PMS-PRAVASTATIN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117778 |
| PMS-PROPAFENONE | 150MG | TABLET | Discontinued | 2017-12-07 | 2018-02-21 | 32089 |
| PMS-PROPAFENONE | 300MG | TABLET | Discontinued | 2018-07-30 | 2018-07-30 | 56891 |
| PMS-QUETIAPINE | 200MG | TABLET | Discontinued | 2022-10-31 | 2022-11-01 | 173173 |
| PMS-RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-06-15 | 2021-10-27 | 117888 |
| PMS-RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-06 | 2018-02-06 | 38830 |
| PMS-RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-06 | 2018-02-06 | 38843 |
| PMS-RALOXIFENE | 60MG | TABLET | Discontinued | 2017-11-17 | 2017-11-17 | 29515 |
| PMS-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2020-04-13 | 2021-10-27 | 111990 |
| PMS-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2020-04-13 | 2021-10-27 | 111993 |
| PMS-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2020-04-13 | 2021-10-27 | 111996 |
| PMS-RAMIPRIL | 5MG | CAPSULE | Discontinued | 2020-04-06 | 2021-10-27 | 111081 |
| PMS-RAMIPRIL | 10MG | CAPSULE | Discontinued | 2020-04-06 | 2021-10-27 | 111084 |
| PMS-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2020-06-17 | 2020-06-17 | 118135 |
| PMS-RAMIPRIL-HCTZ | 2.5MG 12.5MG | TABLET | Discontinued | 2020-06-17 | 2020-06-17 | 118138 |